'lizbeth
07-15-2013, 08:36 PM
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)
http://www.cancer.gov/clinicaltrials/search/view?cdrid=745563&version=HealthProfessional&protocolsearchid=11854401
http://www.cancer.gov/clinicaltrials/search/view?cdrid=745563&version=HealthProfessional&protocolsearchid=11854401